In order to assess the prognostic value of SOX2 amplification on the clinical course of disease in sinonasal SCCs, INVCs and SNUCs, we correlated the SOX2 amplification status with the incidence of tumor recurrence. This evidence concerns the gene SOX2 and neoplasm.